mirvetuximab soravtansine-gynx
AbbVie's Elahere Approved in Europe for FRα-Positive Ovarian Cancer
Elahere's companion diagnostic, Roche's Ventana FOLR1 (FOLR1-2.1) RxDx assay, also garnered CE marking.
ImmunoGen Achieves Full FDA Approval for Elahere in Folate Receptor Alpha-Positive Ovarian Cancer
The agency made the decision after reviewing results from the confirmatory Phase III MIRASOL clinical trial.